How Risky Is Prenatal Genetic Testing? Understanding the Risks of NIPT, Amniocentesis, and CVS

Explore the risks of prenatal genetic testing, including non-invasive and invasive methods, to make informed decisions for you and your baby.

60 views

Prenatal genetic testing has varying levels of risk, depending on the type. Non-invasive prenatal tests (NIPTs), which screen for chromosomal abnormalities through a blood sample from the mother, are very low-risk. However, invasive tests like amniocentesis and chorionic villus sampling (CVS), which involve collecting samples from around the fetus or the placenta, carry a small risk of miscarriage. It’s crucial to discuss the risks and benefits with a healthcare provider to make an informed decision.

FAQs & Answers

  1. What is the difference between non-invasive and invasive prenatal genetic tests? Non-invasive prenatal tests (NIPTs) are done through a simple blood draw from the mother and have minimal risk, while invasive tests like amniocentesis and chorionic villus sampling (CVS) involve sampling fetal or placental tissue and carry a small risk of miscarriage.
  2. How significant is the risk of miscarriage from amniocentesis and CVS? Both amniocentesis and CVS carry a small but measurable risk of miscarriage, generally estimated at less than 1%, but it varies depending on the procedure and patient circumstances.
  3. When should I consider prenatal genetic testing during pregnancy? Prenatal genetic testing is typically offered in the first or second trimester, with NIPTs often done after 10 weeks, and invasive tests like CVS between 10-13 weeks or amniocentesis after 15 weeks, depending on individual risk factors.